Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
WYETH et al v. MEDTRONIC, INC. et al
Case Number:
3:08-cv-01021
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
January 20, 2012
Wyeth, Cordis Stent Patents Are Invalid, Judge Says
A New Jersey federal judge on Thursday ruled that two stent patents by Cordis Corp. and Pfizer Inc. unit Wyeth Pharmaceuticals Inc. are invalid in a suit accusing Abbott Laboratories, Boston Scientific Corp. and Medtronic Inc. of violating the patents.
-
November 19, 2008
Wyeth, Cordis Add Abbott To Medtronic Stent Spat
Wyeth and Johnson & Johnson subsidiary Cordis Corp. have added Abbott Laboratories to their infringement suit against Medtronic Inc. over three stent patents, accusing the Illinois pharmaceutical company of supplying Medtronic with the drug used to coat its allegedly infringing Endeavor stents.